101
|
Gurvitch R, Willson A, Leipsic J, Watts M, Brooks M, Warren R, Joshi S, Wong J, Webb J. Valve Sizing in Transcatheter Aortic Valve Implantation: By How Much is it Safe to Oversize The Short Axis as Determined by Computed Tomography? Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.05.455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
102
|
Starling N, Hawkes EA, Chau I, Watkins D, Thomas J, Webb J, Brown G, Thomas K, Barbachano Y, Oates J, Cunningham D. A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma. Ann Oncol 2011; 23:942-7. [PMID: 21750117 DOI: 10.1093/annonc/mdr317] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND Targeting platelet-derived growth factor receptor-β (PDGFR-β) is a potential strategy to reduce tumour-related interstitial fluid pressure, enhance cytotoxic drug uptake and reduce chemoresistance. This study aimed to define safe doses of gemcitabine plus oxaliplatin when combined with imatinib (potent PDGFR-β inhibitor) in patients with advanced gemcitabine-refractory pancreatic cancer (PC). PATIENTS AND METHODS Using a 3 + 3 dose escalation design, patients of performance status zero or one were entered into five sequential dose levels (DLs) of gemcitabine [day 1, from 400 (DL1) to 1000 mg/m(2) (DL4)] and oxaliplatin [day 2, 85 (DL1-4) and 100 mg/m(2) (DL5)] two weekly. Imatinib 400 mg od was given for 7 days (day minus 2-5) each cycle. RESULTS Twenty-seven patients received 168 cycles in total. Median age was 61 years (44-74 years). Dose-limiting toxicities occurred in two of two patients at DL5 (G4 thrombocytopenia, G3 lethargy), defined as the maximum tolerated dose and one of six patients at DL4 (G3 lethargy). DL4 was expanded. There were 2 of 27 partial responses and 14 of 27 stable disease [disease control 52%, 95% confidence interval (CI) 32% to 71%]. Median progression-free survival and overall survival were 4.6 (95% CI 2.1-7.0) and 5.6 months (95% CI 2.5-8.7), respectively. CONCLUSION In gemcitabine-refractory PC, gemcitabine (1000 mg/m(2)) and oxaliplatin (85 mg/m(2)) can be safely combined with imatinib given on a 7 days on and 7 days off intermittent schedule.
Collapse
|
103
|
Webb J, Khalili A. Hughie Webb. West J Med 2011. [DOI: 10.1136/bmj.d2843] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
104
|
Lee N, Benichi H, Takeno Y, Takeda S, Webb J, Huntington E, Furusawa A. Teleportation of Nonclassical Wave Packets of Light. Science 2011; 332:330-3. [DOI: 10.1126/science.1201034] [Citation(s) in RCA: 152] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
105
|
Vagadia V, Bartholomew P, Kelly M, Handley G, Kelly C, Bridges M, Ruddick S, Malik R, Gilleece Y, Fisher M, Walker-Bone K, Selvan S, Collins DA, Meryon I, Pattle J, Scurr C, Davies G, Callan M, Mercieca C, Down M, Webb J, Shipley J, Bhalla AK, Poole KE, Treece GM, Ridgway GR, Mayhew PM, Borggrefe J, Gee AH, Mehta P, Nelson M, Boag F, Oldroyd AG, Halsey J, Goodson NJ, Greenbank C, Evans B, Bukhari M, Azagra R, Roca G, Encabo G, Aguye A, Zwart M, Casado E, Iglesias M, Puchol N, Sola S, Guell S, Harvey NC, Garrett E, Sheppard A, McLean C, Lillycrop K, Burdge G, Slater-Jefferies J, Rodford J, Crozier S, Inskip H, Starling Emerald B, Gale C, Hanson M, Gluckman P, Godfrey K, Cooper C, Edwards MH, Jameson K, Denison H, Aihie Sayer A, Cooper C, Dennison E, Cole Z, Harvey NC, Kim M, Robinson S, Inskip H, Godfrey KM, Cooper C, Dennison E, Clark EM, Morrison L, Gould V, Cuming M, Tobias J. Osteoporosis and metabolic bone disease: 73. Do Low Vitamin D Levels Predict Osteoporosis? Rheumatology (Oxford) 2011. [DOI: 10.1093/rheumatology/ker042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
106
|
Willson A, Leipsic J, Gurvitch R, Toggweiler S, Binder R, Wood D, Ye J, Cheung A, Webb J. Late Structural Integrity of Balloon Expandable Stents used for Transcatheter Aortic Valve Replacement (TAVR): Assessment by Multi Detector Computerised Tomography (MDCT). Heart Lung Circ 2011. [DOI: 10.1016/j.hlc.2011.05.331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
107
|
Willson A, Webb J, Gurvitch R, Binder R, Toggweiler S, Wood D, Ye J, Cheung A, Leipsic J. Post Implantation Geometry of the Edwards SAPIEN XT Valve as Assessed by Multidetector Computerised Tomography. Heart Lung Circ 2011. [DOI: 10.1016/j.hlc.2011.05.353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
108
|
Gurvitch R, Webb J, Yuan R, Johnson M, Hague C, Willson A, Toggweiler S, Wood D, Ye J, Moss R, Thompson C, Leipsic J. Aortic Annulus Diameter Determination by Multidetector Computed Tomography: Reproducibility, Applicability and Implications for Transcatheter Aortic Valve Replacement. Heart Lung Circ 2011. [DOI: 10.1016/j.hlc.2011.05.397] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
109
|
Gurvitch R, Willson A, Rodes-Cabau J, Bagur R, Toggweiler S, Wood D, Cheung A, Ye J, Lee M, Dumont E, Webb J. Transcatheter Aortic Valve Implantation—Multicentre Study Evaluating the Clinical Outcomes of Patients with PARTNER Trial Exclusions. Heart Lung Circ 2011. [DOI: 10.1016/j.hlc.2011.05.378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
110
|
Starling N, Hawkes EA, Chau I, Watkins DJ, Thomas J, Webb J, Brown G, Thomas K, Oates JR, Cunningham D. A dose-escalation study of gemcitabine (Gem) plus oxaliplatin (Ox) in combination with imatinib in patients (pts) with gemcitabine-refractory advanced pancreatic adenocarcinoma (PC). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.4155] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
111
|
Hawkes EA, Chau I, Thomas K, Oates JR, Webb J, Costello C, Johnson PW, Cunningham D. RCHOPB: Feasibility study of RCHOP plus bevacizumab (B) in patients (pts) with diffuse large B-cell lymphoma (DLBCL). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.tps304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
112
|
Watkins DJ, Starling N, Chau I, Thomas J, Webb J, Oates JR, Brown G, Thomas K, Cunningham D. The combination of a chemotherapy doublet (gemcitabine plus capecitabine) with a biologic doublet (bevacizumab plus erlotinib) in patients with advanced pancreatic adenocarcinoma: The TARGET study. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.4036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
113
|
Gurvitch R, Wood D, Leipsic J, Tay E, Nietlispach F, Wijesinghe N, Cheung A, Lichtenstein S, Munt B, Webb J. Utility of Multislice Computed Tomography in Predicting the Correct Angiographic Angle for Deployment of Transcatheter Aortic Valves. Heart Lung Circ 2010. [DOI: 10.1016/j.hlc.2010.06.491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
114
|
Nietlispach F, Wijesinghe N, Gurvitch R, Tay E, Webb J. An Embolic Deflection Device for Aortic Valve Interventions. Heart Lung Circ 2010. [DOI: 10.1016/j.hlc.2010.06.948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
115
|
Gurvitch R, Tay E, Wood D, Leipsic J, Lichtenstein S, Thompson C, Carere R, Wijesinghe N, Nietlispach F, Boone R, Cheung A, Webb J. Transcatheter Aortic Valve Implantation: Durability of Clinical and Haemodynamic Outcomes Beyond Three Years in a Large Patient Cohort. Heart Lung Circ 2010. [DOI: 10.1016/j.hlc.2010.06.1038] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
116
|
Tay E, Gurvitch R, Wijesinghe N, Nietlispach F, Wood D, Ye J, Cheung A, Carere R, Lichtenstein S, Thompson C, Webb J. Cerebrovascular Events Following Transcatheter Aortic Valve Replacement—Incidence, Predictors and Timing of Events. Heart Lung Circ 2010. [DOI: 10.1016/j.hlc.2010.06.956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
117
|
Nietlispach F, Johnson M, Moss R, Gurvitch R, Tay E, Wijesinghe N, Thompson C, Webb J. Transcatheter Closure of Paravalvular Defects Using a New Purpose-Specific Occluder. Heart Lung Circ 2010. [DOI: 10.1016/j.hlc.2010.06.1039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
118
|
Gurvitch R, Tay E, Nietlispach F, Wijesinghe N, Wood D, Cheung A, Thompson C, Ye J, Lichtenstein S, Webb J. Transcatheter Aortic Valve Implantation—Single Centre Outcomes From the First 270 High-Risk Patients. Heart Lung Circ 2010. [DOI: 10.1016/j.hlc.2010.06.1036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
119
|
Wijesinghe N, Masson J, Nietlispach F, Tay E, Gurvitch R, Wood D, Webb J. A Novel Real-Time Image Processor to Facilitate Transcatheter Aortic Valve Implantation. The Paieon's C-THV System. Heart Lung Circ 2010. [DOI: 10.1016/j.hlc.2010.06.944] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
120
|
O'halloran D, Webb J. West J Med 2009; 339:b3602-b3602. [DOI: 10.1136/bmj.b3602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
121
|
Stewart J, Northrup S, Webb J, Polyachenko N. QS364. Hyperthermia Enhances the Cytotoxic Effect of Oxaliplatin in Colon Cancer Cells. J Surg Res 2009. [DOI: 10.1016/j.jss.2008.11.673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
122
|
Samuel S, Walsh R, Webb J, Robins A, Potten C, Mahida YR. Characterization of putative stem cells in isolated human colonic crypt epithelial cells and their interactions with myofibroblasts. Am J Physiol Cell Physiol 2008; 296:C296-305. [PMID: 19073897 DOI: 10.1152/ajpcell.00383.2008] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Colonic epithelial stem cells are believed to be located at the crypt base where they have previously been shown to express musashi-1. The colonic stem cell niche, which includes extracellular matrix and myofibroblasts (together with other cell types), is likely to be important in maintaining the function of the progenitor cells. The aims of our studies were to characterize stem cells in isolated and disaggregated human colonic crypt epithelial cells and investigate their interactions with monolayers of primary human colonic myofibroblasts. In unfractionated preparations of disaggregated colonic crypts, musashi-1 positive cells preferentially adhered to colonic myofibroblasts, despite the presence of excess blocking anti-beta(1)-integrin antibody. These adherent epithelial cells remained viable for a number of days and developed slender processes. Cells with side population characteristics (as demonstrated by ability to expel the dye Hoechst 33342) were consistently seen in the isolated colonic crypt epithelial cells. These side population cells expressed musashi-1, beta(1)-integrin, BerEP4, and CD133. Sorted side population crypt epithelial cells also rapidly adhered to primary colonic myofibroblasts. In conclusion, in preparation of isolated and disaggregated human colonic crypts, cells with stem cell characteristics preferentially adhere to primary human colonic myofibroblasts in a beta(1)-integrin-independent fashion.
Collapse
|
123
|
Langton DJ, Jameson SS, Joyce TJ, Webb J, Nargol AVF. The effect of component size and orientation on the concentrations of metal ions after resurfacing arthroplasty of the hip. ACTA ACUST UNITED AC 2008; 90:1143-51. [PMID: 18757952 DOI: 10.1302/0301-620x.90b9.20785] [Citation(s) in RCA: 270] [Impact Index Per Article: 16.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Increased concentrations of metal ions after metal-on-metal resurfacing arthroplasty of the hip remain a concern. Although there has been no proven link to long-term health problems or early prosthetic failure, variables associated with high metal ion concentrations should be identified and, if possible, corrected. Our study provides data on metal ion levels from a series of 76 consecutive patients (76 hips) after resurfacing arthroplasty with the Articular Surface Replacement. Chromium and cobalt ion concentrations in the whole blood of patients with smaller (<or= 51 mm) femoral components were significantly higher than in those with the larger (>or= 53 mm) components (p < 0.01). Ion concentrations in the former group were significantly related to the inclination (p = 0.01) and anteversion (p = 0.01) of the acetabular component. The same relationships were not significant in the patients with larger femoral components (p = 0.61 and p = 0.49, respectively). Accurate positioning of the acetabular component intra-operatively is essential in order to reduce the concentration of metal ions in the blood after hip resurfacing arthroplasty with the Articular Surface Replacement implant.
Collapse
|
124
|
Hayashi A, Webb J, Baker C, Adeli K. Expression levels of intestinal lipid transporters in the fructose fed hamster model of insulin resistance. ATHEROSCLEROSIS SUPP 2008. [DOI: 10.1016/j.atherosclerosissup.2008.09.421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
125
|
Sutton PA, Li S, Webb J, Solomon K, Brazier J, Mahida YR. Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function. Clin Exp Immunol 2008; 153:439-47. [PMID: 18505424 DOI: 10.1111/j.1365-2249.2008.03690.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Clostridium difficile induces mucosal inflammation via secreted toxins A and B and initial interactions between the toxins and intestinal epithelial cells (which lead to loss of barrier function) are believed to be important in disease pathogenesis. Secreted toxin-specific antibodies may inhibit such interactions. Using the Caco-2 epithelial cell line, we have investigated the use of an anti-toxin A monoclonal antibody (ATAA) in providing protection against toxin A-mediated disruption of epithelial barrier function (assessed by measurement of transepithelial electrical resistance and luminal to basolateral flux of labelled dextran). In contrast to free antibody, ATAA conjugated to sepharose beads was more effective in neutralizing the activity of purified toxin A. Sepharose bead-conjugated ATAA was subsequently used to investigate the contribution of toxin A in epithelial injury mediated by C. difficile supernatant samples (containing toxins A, B and other products). Loss of barrier function mediated by apical application of supernatant samples of reference and epidemic 027 strains of C. difficile was abrogated by neutralization of toxin A. However, this was not the case when the supernatant samples were applied to the basal surface of epithelial monolayers. In conclusion, our studies have shown that (i) sepharose bead-conjugated ATAA is more effective in neutralizing toxin A than free antibody and (ii) when the apical (luminal) surface of epithelial monolayers is exposed to the secretory products of reference and 027 strains of C. difficile, toxin A is required for the initial injury that leads to loss of barrier function.
Collapse
|